Dr. Martens (LON:DOCS) Trading Down 9.6% – Should You Sell?

Dr. Martens plc (LON:DOCS)’s stock price traded down 9.6% during trading on Thursday . The stock traded as low as GBX 72.30 and last traded at GBX 73.80. 4,733,644 shares traded hands during mid-day trading, an increase of 115% from the average session volume of 2,203,986 shares. The stock had previously closed at GBX 81.60.

Wall Street Analyst Weigh In

Separately, Peel Hunt reaffirmed a “buy” rating on shares of Dr. Martens in a report on Thursday. One investment analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of GBX 6,000.

Dr. Martens Trading Down 9.6%

The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. The stock has a market cap of £713.15 million, a P/E ratio of 147.60, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a 50-day simple moving average of GBX 90.64 and a 200-day simple moving average of GBX 80.35.

Dr. Martens (LON:DOCS) last announced its earnings results on Thursday, November 20th. The company reported GBX (0.90) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, sell-side analysts forecast that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Ije Nwokori sold 298,675 shares of the stock in a transaction that occurred on Wednesday, October 15th. The shares were sold at an average price of GBX 90, for a total transaction of £268,807.50. Also, insider Giles Wilson purchased 105,838 shares of the stock in a transaction that occurred on Monday, September 1st. The stock was bought at an average cost of GBX 91 per share, with a total value of £96,312.58. Over the last quarter, insiders have bought 136,960 shares of company stock worth $12,460,163 and have sold 434,460 shares worth $39,131,400. 2.80% of the stock is currently owned by corporate insiders.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.